BUPRENORPHINE FURAN
UNII Z7N3HL2G9P

Substance Identification & Data

This profile provides standardized clinical and technical data for Buprenorphine Furan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z7N3HL2G9P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 89663-73-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Z7N3HL2G9P
CAS Registry Number
89663-73-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BUPRENORPHINE FURAN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C28H37NO3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
MFRSJMQUIFQWSF-HITWJPLNSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
93488712
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C(N1[C@]2([C@]34[C@@]5([C@]([C@]6([C@](C3)(C(C)(C)C(C)(C)O6)[H])CC4)(Oc7c5c(C2)ccc7O)[H])CC1)[H])C8CC8

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Buprenorphine Furan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

BUPRENORPHINE FURAN
BUPRENORPHINE FURANYL IMPURITY
BUPRENORPHINE HYDROCHLORIDE IMPURITY I [EP IMPURITY]
BUPRENORPHINE IMPURITY I [EP IMPURITY]

Systematic Nomenclature

(2S,6R,14R)-5-(CYCLOPROPYLMETHYL)-17,17,18,18-TETRAMETHYL-13,16-DIOXA-5-AZAHEPTACYCLO(13.5.2.12,8.01,6.02,14.015,19.012,23)TRICOSA-8(23),9,11-TRIEN-11-OL
(4BS,8R,8AS,9AR,12AR,12BR)-7-(CYCLOPROPYLMETHYL)-5,6,7,8,9,9A,10,11-OCTAHYDRO-10,10,11,11-TETRAMETHYL-8A,12A-ETHANO-4,8-METHANO-12BH-BENZOFURO(3,2-E)FURO(2,3-G)ISOQUINOLIN-1-OL
17-(CYCLOPROPYLMETHYL)-4,4,5,5-TETRAMETHYL-4,5DIHYDRO-(7.BETA.H)-6.ALPHA.,14-ETHANO-(5.BETA.H)-DIFURANO(2',3',4',5':4,12,13,5;2,3:6,7)-14.ALPHA.-MORPHINAN-3-OL
8A,12A-ETHANO-4,8-METHANO-12BH-BENZOFURO(3,2-E)FURO(2,3-G)ISOQUINOLIN-1-OL, 7-(CYCLOPROPYLMETHYL)-5,6,7,8,9,9A,10,11-OCTAHYDRO-10,10,11,11-TETRAMETHYL-, (8R-(4BS*,8.ALPHA.,8A.ALPHA.,9A.BETA.,12A.ALPHA.,12B.BETA.))-

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound